Shares of Ryan Specialty Holdings Inc. (NYSE:RYAN – Get Free Report) have earned an average recommendation of “Hold” from the nineteen ratings firms that are currently covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a sell rating, nine have assigned a hold rating and eight have issued a buy rating on the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $50.00.
RYAN has been the topic of several recent research reports. UBS Group cut their price objective on shares of Ryan Specialty from $52.00 to $50.00 and set a “buy” rating on the stock in a research report on Wednesday, July 8th. Citigroup dropped their price target on shares of Ryan Specialty from $55.00 to $50.00 and set a “buy” rating on the stock in a research note on Monday, May 4th. Wolfe Research downgraded shares of Ryan Specialty from an “outperform” rating to a “peer perform” rating in a report on Thursday, July 9th. Zacks Research raised shares of Ryan Specialty from a “strong sell” rating to a “hold” rating in a research note on Tuesday, June 30th. Finally, Atlantic Securities set a $69.00 price objective on shares of Ryan Specialty in a research note on Wednesday, July 15th.
Check Out Our Latest Stock Analysis on Ryan Specialty
Ryan Specialty Stock Performance
Ryan Specialty (NYSE:RYAN – Get Free Report) last posted its quarterly earnings results on Thursday, April 30th. The company reported $0.47 earnings per share for the quarter, topping analysts’ consensus estimates of $0.43 by $0.04. The company had revenue of $795.23 million during the quarter, compared to the consensus estimate of $781.44 million. Ryan Specialty had a return on equity of 41.33% and a net margin of 8.21%.The business’s quarterly revenue was up 15.2% on a year-over-year basis. During the same period last year, the business earned $0.39 EPS. Analysts anticipate that Ryan Specialty will post 2.06 earnings per share for the current fiscal year.
Ryan Specialty announced that its Board of Directors has authorized a share repurchase program on Tuesday, May 26th that authorizes the company to repurchase $300.00 million in shares. This repurchase authorization authorizes the company to buy up to 3.5% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company’s board of directors believes its shares are undervalued.
Ryan Specialty Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Tuesday, May 26th. Shareholders of record on Tuesday, May 12th were issued a dividend of $0.13 per share. This represents a $0.52 annualized dividend and a yield of 1.2%. The ex-dividend date was Tuesday, May 12th. Ryan Specialty’s dividend payout ratio (DPR) is 67.53%.
Insider Transactions at Ryan Specialty
In related news, EVP Mark Stephen Katz purchased 3,215 shares of the firm’s stock in a transaction dated Wednesday, June 3rd. The stock was bought at an average price of $31.07 per share, for a total transaction of $99,890.05. Following the purchase, the executive vice president owned 4,332 shares in the company, valued at $134,595.24. The trade was a 287.82% increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director John W. Rogers, Jr. acquired 7,500 shares of the stock in a transaction dated Wednesday, June 10th. The shares were bought at an average cost of $35.16 per share, for a total transaction of $263,700.00. Following the acquisition, the director owned 117,933 shares in the company, valued at $4,146,524.28. The trade was a 6.79% increase in their position. The disclosure for this purchase is available in the SEC filing. In the last quarter, insiders purchased 130,715 shares of company stock worth $4,263,590. 52.03% of the stock is owned by corporate insiders.
Hedge Funds Weigh In On Ryan Specialty
A number of institutional investors have recently modified their holdings of RYAN. Vulcan Value Partners LLC lifted its stake in shares of Ryan Specialty by 631.7% in the fourth quarter. Vulcan Value Partners LLC now owns 4,621,079 shares of the company’s stock worth $238,536,000 after buying an additional 3,989,502 shares during the last quarter. T. Rowe Price Investment Management Inc. grew its stake in Ryan Specialty by 79.9% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 7,552,002 shares of the company’s stock valued at $389,910,000 after buying an additional 3,353,926 shares during the last quarter. Adage Capital Partners GP L.L.C. grew its stake in Ryan Specialty by 1,510.0% in the 4th quarter. Adage Capital Partners GP L.L.C. now owns 1,610,000 shares of the company’s stock valued at $83,124,000 after buying an additional 1,510,000 shares during the last quarter. Norges Bank bought a new position in Ryan Specialty in the 4th quarter worth $60,546,000. Finally, Focus Partners Wealth bought a new position in Ryan Specialty in the 4th quarter worth $43,506,000. Institutional investors own 84.82% of the company’s stock.
About Ryan Specialty
Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.
Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.
See Also
- Five stocks we like better than Ryan Specialty
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.
